Relevance of accurate QT correction in the assessment of long QT syndrome
Kanniainen, Matias; Pukkila, Teemu; Aalto-Setälä, Katriina; Räsänen, Esa (2024-11)
Avaa tiedosto
Lataukset:
Kanniainen, Matias
Pukkila, Teemu
Aalto-Setälä, Katriina
Räsänen, Esa
11 / 2024
153790
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202410019027
https://urn.fi/URN:NBN:fi:tuni-202410019027
Kuvaus
Peer reviewed
Tiivistelmä
Background: Long QT syndrome (LQTS) is a genetic cardiac disease, where the corrected QT (QTc) interval is prolonged. It can cause arrhythmias and lead to a sudden cardiac death. Duration of the QT interval depends on the heart rate and this dependency is treated with QT correction. However, the current QT correction methods have well known problems and limitations. Objective: We study the relevance of QT correction method in evaluating the risk of LQTS. We evaluate the reliability of the present and recently developed QT correction methods to discriminate LQTS subjects from healthy controls. Methods: We use the clinically prevalent QT correction methods, particularly Bazett and Fridericia, in comparison with the recently developed AccuQT method. The data of healthy controls and LQTS subjects is extracted from the Rochester THEW database. The analysis accounts for sex, major LQTS subtypes, and beta-blocker treatment. Results: QT values corrected with AccuQT discriminate the healthy and LQTS samples with the best accuracy, leading to (TP, TN) = (0.87, 0.65) with the conventional 450 ms threshold for LQTS. Fridericia correction yields lower sensitivity (0.71), but comparable balanced accuracy, whereas Bazett shows significantly less accurate results due to overcorrection at lower heart rates. Conclusion: The selected QT correction method is important in the identification of LQTS. In particular, the use of Bazett correction should be questioned. Fridericia correction yields good results with respect to its simplicity. AccuQT has the best accuracy out of all the methods for LQTS discrimination. For practical applicability, however, AccuQT needs further validation in realistic clinical conditions.
Kokoelmat
- TUNICRIS-julkaisut [18603]